Authors


Eric Weil, MD

Latest:

Intensive Care Management of a Complex Medicaid Population: A Randomized Evaluation

The authors present findings of a randomized evaluation of Medicaid patients at an academic medical center, which found that intensive care management was associated with reduced total medical expense.


Jennifer K. Taylor, PhD

Latest:

Strategies for Identifying and Channeling Patients for Depression Care Management

This article examines screening strategies for possible depression in the context of a care management program for chronically ill Medicare recipients.


Amber Watson, PharmD

Latest:

Medical Utilization Surrounding Initial Opioid-Related Diagnoses by Coding Method

Medical utilization profiles of commercially insured members with opioid-related disorders differ depending on the code used to document the initial diagnosis in administrative claims.


Amisha Wallia, MD, MS

Latest:

Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.


David Introcaso, PhD

Latest:

The Need to Level the Playing Field Between Accountable Care Organizations and Medicare Advantage

For several reasons, including meeting the HHS Secretary’s Medicare quality and value payment goals, the ACO program needs to reformed to equate with Medicare Advantage.




Jonathan Ratner, PhD

Latest:

Pragmatic Clinical Trials: US Payers' Views on Their Value

Payers like key traits of pragmatic clinical trials, but are wary of pharmaceutical companies and plan to carefully scrutinize this new, appealing type of evidence.


Eleanor M. Perfetto, PhD, MS

Latest:

Impact of Formulary Restrictions on Medication Use and Costs

Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.


Glenn A. Phillips, PhD

Latest:

Cost of Post-Traumatic Stress Disorder vs Major Depressive Disorder Among Patients Covered by Medicaid or Private Insurance

Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.





Grace M. Hildenbrand, MA

Latest:

Preventive/Office Visit Patient Knowledge and Their Insurance Information Gathering Perceptions

Patients have an incomplete understanding of what constitutes no-cost preventive care services. Ease of obtaining information from insurance companies can significantly affect whether patients are charged correctly.


Andrew L. Masica, MD, MSCI

Latest:

Patient Safety-Focused Medication Therapy Management: Challenges Affecting Future Implementation

Lessons learned from implementation of a pharmacist-delivered medication therapy management intervention in primary care can inform future studies and be adopted into real-world clinical settings.





John W. Morgan, MD

Latest:

Advancing Health Equity Through Medication Formulary Policy

Medication formulary policies represent a key determinant of access to medication and can be leveraged to advance pharmacoequity and health equity writ large.


Stacey M. Coleman, BSN, RN

Latest:

US Prevalence of Upper Gastrointestinal Symptoms: A Systematic Literature Review

Systematic review and meta-analysis suggest that upper gastrointestinal symptoms and disorders are common to inhabitants of the United States.


Carolyn A. Watts, PhD

Latest:

A Physician-led Accountable Care Organization: From Award to Implementation

Gaps in ACO implementation readiness are identified as appointment reminders, referral follow-ups, care management, care transition alerts, clinical quality measure knowledge, and resources.





Thomas Isaac, MD, MBA, MPH

Latest:

Measuring Overuse With Electronic Health Records Data

Electronic health records data can accurately quantify overuse of clinical services and the risk factors that may trigger low-value testing and screening.


Jeffrey Lynn Hulstein, PharmD, CDE

Latest:

Impact of Clinical Pharmacy Services on Outcomes and Costs for Indigent Patients With Diabetes

Clinical pharmacy specialists impact patient care through improvements in clinical outcomes for diabetes, hypertension, and dyslipidemia via clinical interventions and promotion of medication adherence.





AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo